{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"OtherAbstract": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "SpaceFlightMission": [], "KeywordList": [], "InvestigatorList": [], "PMID": "9525109", "DateCompleted": {"Year": "1998", "Month": "04", "Day": "23"}, "DateRevised": {"Year": "2016", "Month": "11", "Day": "24"}, "Article": {"Language": ["eng"], "ArticleDate": [], "ELocationID": [], "Journal": {"ISSN": "0032-0943", "JournalIssue": {"Volume": "64", "Issue": "2", "PubDate": {"Year": "1998", "Month": "Mar"}}, "Title": "Planta medica", "ISOAbbreviation": "Planta Med"}, "ArticleTitle": "Structure-activity relationships of imperialine derivatives and their anticholinergic activity.", "Pagination": {"StartPage": "172", "EndPage": "174", "MedlinePgn": "172-4"}, "Abstract": {"AbstractText": ["In order to check the structure-activity relationship and prepare more potent derivatives of imperialine with anticholinergic activity, imperialinol (2), 3 beta-acetoxyimperialine (3), 3 beta-propionoxyimperialine (4), and 3 beta-butyroxyimperialine (5) were prepared. Compounds 4 and 5 displayed better anticholinergic activity against muscarinic receptors of the heart and brain than imperialine (1). The decrease in activity in 2 showed the importance of the 6-keto functionality in imparting the anticholinergic activity."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [], "LastName": "Atta-ur-Rahman"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Choudhary", "ForeName": "M I", "Initials": "MI"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Farooq", "ForeName": "A", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Anjum", "ForeName": "S", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Baumgold", "ForeName": "J", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Sener", "ForeName": "B", "Initials": "B"}], "PublicationTypeList": ["Letter", "Research Support, U.S. Gov't, Non-P.H.S."]}, "MedlineJournalInfo": {"Country": "Germany", "MedlineTA": "Planta Med", "NlmUniqueID": "0066751", "ISSNLinking": "0032-0943"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Alkaloids"}, {"RegistryNumber": "0", "NameOfSubstance": "Cevanes"}, {"RegistryNumber": "0", "NameOfSubstance": "Cholinergic Antagonists"}, {"RegistryNumber": "0", "NameOfSubstance": "Receptors, Muscarinic"}, {"RegistryNumber": "JKN43410XZ", "NameOfSubstance": "peiminine"}], "MeshHeadingList": [{"QualifierName": ["chemistry", "isolation & purification", "pharmacology"], "DescriptorName": "Alkaloids"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["chemistry", "isolation & purification", "pharmacology"], "DescriptorName": "Cevanes"}, {"QualifierName": ["chemistry", "isolation & purification", "pharmacology"], "DescriptorName": "Cholinergic Antagonists"}, {"QualifierName": [], "DescriptorName": "Guinea Pigs"}, {"QualifierName": ["drug effects", "physiology"], "DescriptorName": "Heart"}, {"QualifierName": [], "DescriptorName": "Heart Atria"}, {"QualifierName": ["drug effects", "physiology"], "DescriptorName": "Hippocampus"}, {"QualifierName": [], "DescriptorName": "In Vitro Techniques"}, {"QualifierName": [], "DescriptorName": "Molecular Structure"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["drug effects", "physiology"], "DescriptorName": "Receptors, Muscarinic"}, {"QualifierName": [], "DescriptorName": "Structure-Activity Relationship"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1998", "Month": "4", "Day": "3"}, {"Year": "1998", "Month": "4", "Day": "3", "Hour": "0", "Minute": "1"}, {"Year": "1998", "Month": "4", "Day": "3", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["9525109", "10.1055/s-2006-957397"]}}]}